SHP-1 and SHP-2 bind pBTLA

Stable Identifier
R-HSA-389941
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Upon BTLA activation, its phosphorylated tyrosine residues facilitate the recruitment of SH2-domain-containing phosphatases, SHP-1 and SHP-2. While the specific targets of these phosphatases in BTLA signaling are not well-defined, they are thought to play a role in dephosphorylating signaling intermediates downstream of antigen receptors in lymphocytes or potentially modulate the PI3K-AKT pathway, impacting cell survival and immune response (Watanabe et al. 2003).
Literature References
PubMed ID Title Journal Year
12796776 BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Hurchla, MA, Fallarino, F, Zimmerman, N, Sedý, JR, Gavrieli, M, Loftin, SK, Zang, X, Murphy, KM, Sim, J, Murphy, TL, Russell, JH, Allison, JP, Yang, J, Watanabe, N

Nat Immunol 2003
16932752 Balancing co-stimulation and inhibition with BTLA and HVEM

Sedý, JR, Nelson, CA, Murphy, KM

Nat Rev Immunol 2006
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!